Gilles Ringuette

BIOVECTRA

Expertise in both microbial fermentation and chemical synthesis allows us to tackle today's development pipeline's increasingly complex molecules. In fact, we thrive on the vexing challenges few CDMOs would have either the expertise or desire to address. Bold vision, along with the passion and commitment to make that vision reality, is at the heart of our organization. We are a forward-thinking, North American CDMO Pharmaceutical company specializing in clinical-to-commercial scale production capabilities for: Synthetic small molecules Fermented small molecules Highly potent APIs Biologics Bioreagents Flexibility, creativity, and dedication to process optimization are at the heart of our method and process development as well as quality and compliance efforts. We assure the programs advance on time and with the highest quality outcomes under our project managers' leadership.